Prognostic Factors for Survival in Patients With Cholangiocarcinoma
Rigshospitalet, Denmark
2,000 participants
Feb 1, 2024
OBSERVATIONAL
Conditions
Summary
The objective of this retrospective study is to determine the survival rates of CCA patients based on different therapeutic approaches. Additionally, we aim to investigate the risk factors associated with poor survival within a cohort of patients treated over a seven-year period across four Danish hospitals. We anticipate that our findings could provide additional evidence for clinical decision-making, improve patient outcomes, and contribute to the knowledge in the field.
Eligibility
Inclusion Criteria1
- Patients' eligibility for this study is contingent on a diagnosis of CCA confirmed by the MDT from Aalborg Universitetshospital, Aarhus Universitetshospital, Odense Universitetshospital, and Rigshospitalet in Denmark from 2013 to 2020.
Exclusion Criteria1
- We will exclude from the analysis all records with more than one interventions. Additionally, all patients whose cholangiocarcinoma diagnosis was canceled following the MDT meeting will be also excluded, as well those with inconsistent data regarding date of reference to the MDT.
Interventions
Curative treatment
Chemotherapeutic medications
Chemotherapeutic medications after surgery
Radiotherapy
Symptomatic treatment, non-curative treatment
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06369480